Health Care/Hospital
IMG Says 71% of U.S. International Travelers Are Planning to Travel Abroad in 2021
- IMG's Future of Travel Survey collected responses from their U.S. members with past international travel experience (42% of respondents reported 3+ international trips per year) - Survey results reveal travel insights such as willingness to travel internationally, importance of safety precauti...
2021-04-16 21:30
2902
Qilu Pharmaceutical and Peptron Sign License Agreement for anti-MUC1 ADC
SEOUL, South Korea and JINAN, China, April 16, 2021 /PRNewswire/ -- Peptron, Inc. ("Peptron", KOSDAQ: 087010), aSouth Korea-based biotech company, and Qilu Pharmaceutical ("Qilu"), a leading vertically integrated pharmaceutical company focused on discovering, developing, manufacturing and commerc...
2021-04-16 20:00
3748
Kintor Pharmaceuticals Announced Successful Dosing of the First Batch of Patients for Acne Vulgaris Phase I/II Clinical Trial of Pyrilutamide
SUZHOU, China, April 16, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939), a clinical-stage biotechnology company developing small molecule and biological therapeutics, announced today the clinical trial of Pyrilutamide as a treatment for the acne vulgaris has completed the first b...
2021-04-16 18:29
5030
Chipscreen received a Phase 1b/2 clinical trial of Chiauranib/CS2164 IND clearance from the US Food and Drug Administration (FDA)
SHENZHEN, China, April 16, 2021 /PRNewswire/ -- Shenzhen Chipscreen Biosciences , aChina headquartered biopharmaceutical company developing and marketing novel drugs based on its unique technology of Chemical Genomics Drug discovery platform, today announces that it has received Investigational Ne...
2021-04-16 18:24
1935
Report from the Extraordinary General Meeting 2021 in Elekta
STOCKHOLM, April 16, 2021 /PRNewswire/ -- Elekta AB (publ) (EKTA-B.ST) has held an Extraordinary General Meeting on Friday16 April 2021. Due to Covid-19, the Meeting was conducted by advance postal vote, without the physical attendance of shareholders, representatives or third parties. A summary ...
2021-04-16 16:59
6790
Radcliffe Cardiology Launches New Title: JAPSC: Journal of Asian Pacific Society of Cardiology on Behalf of the Asian Pacific Society of Cardiology
LONDON, April 16, 2021 /PRNewswire/ -- The Asian Pacific Society of Cardiology and Radcliffe Cardiology are pleased to announce the launch of a new open access title,JAPSC: Journal of Asian Pacific Society of Cardiology. Launching in 2021, JAPSC will be led by Dr Yeo Khung Keong as Editor-in-Chie...
2021-04-16 13:00
1725
GT Apeiron Therapeutics Strengthens Advisory Board
SHANGHAI, April 16, 2021 /PRNewswire/ -- Keith Lenden and Dr. Honggang Bi has been appointed as new members of the Advisory Board at GT Apeiron Therapeutics, an AI empowered drug discovery start-up developing oncology therapeutics. Mr. Lenden and Dr. Bi add further expertise in drug discovery inn...
2021-04-16 09:00
1805
Transcenta Announced Presentation of Preclinical Data of TST005 at 2021 AACR Virtual Annual Meeting
SUZHOU, China, April 15, 2021 /PRNewswire/ -- Transcenta Holding Limited (Transcenta), a clinical stage global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, presented preclinical data of TST005, a bi-functio...
2021-04-16 08:00
1197
New Pathway Launched for Pioneering Life Science Companies Seeking Japanese Market Entry
TOKYO, April 15, 2021 /PRNewswire/ -- Today, pioneering life science organizations seeking to navigate Japanese market entry gained a new pathway. Shonan Health Innovation Park ("Shonan iPark", Kanagawa Prefecture,Japan) announced today new membership offerings for innovation and expansion-focuse...
2021-04-15 21:00
1244
Kintor Pharmaceutical Announces AR-PROTAC (GT20029) Approved for Acne and Androgenic Alopecia Clinical Trials in China
SUZHOU, China, April 15, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (stock code 9939.HK, "Kintor Pharmaceutical" or the "Company"), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced that it has received approval from t...
2021-04-15 18:20
4734
Generali Redefines Critical Illness Coverage with Unlimited Claims[1] even After Major Claims are Made
HONG KONG, April 15, 2021 /PRNewswire/ -- Generali Hong Kong introduces
LionGuardian Beyondand LionGuardian PlusOne, enhanced critical illness plans
with unlimited claims[1] for the most concerned critical illnesses[2] - cancer,
stroke and heart attacks.
2021-04-15 18:19
2495
![Generali Redefines Critical Illness Coverage with Unlimited Claims[1] even After Major Claims are Made](https://mma.prnasia.com/media2/1488581/ge___lgb_office_poster_bilingual_preview.jpg?p=medium600)
Exyte to build Dexcom's first manufacturing facility in Asia
STUTTGART, Germany and PENANG, Malaysia, April 15, 2021 /PRNewswire/ -- Exyte, world-renowned for the design and construction of high-tech facilities, has been awarded a fast-track project for Dexcom inPenang, Malaysia. This is the first manufacturing facility for the U.S.-based diabetes care tec...
2021-04-15 18:07
2643
LightAir IonFlow fights the spread of COVID-19
STOCKHOLM, April 15, 2021 /PRNewswire/ -- LightAir IonFlow virus inhibitor is scientifically and independently proven on viruses in the air and on surfaces, and together with the development of vaccines, can actively contribute to halting the spread of COVID-19. New tests from a leading European...
2021-04-15 17:45
1763
Juniper Biologics Announces the Appointment of Raman Singh as Chief Executive
SINGAPORE, April 15, 2021 /PRNewswire/ -- Juniper Biologics, a science-led healthcare company focused on researching, developing & commercialising novel therapies, has announced the appointment of celebrated pharmaceutical executive Raman Singh to the role of Chief Executive. Juniper Biologics wi...
2021-04-15 16:30
2060
Mentice appoints Pontus Appelqvist as Vice President and GM for Asia Pacific
STOCKHOLM, April 15, 2021 /PRNewswire/ -- Mentice AB (STO: MNTC), a leading supplier of high-tech solutions for simulation in the medical sector, with a focus on endovascular procedures, today announced the appointment of Pontus Appelqvist as Vice President and General Manager forAsia Pacific. Po...
2021-04-15 16:21
1867
New clinical study shows JOYSBIO COVID-19 neutralizing antibody rapid test nearly 98% accurate in verifying antibodies after vaccination
TIANJIN, China, April 15, 2021 /PRNewswire/ -- In a major breakthrough for testing COVID-19 immunity, JOYSBIO, a Chinese medical device manufacturer, just announced the completion of a clinical study inItaly, showing their COVID-19 neutralizing antibody rapid test kit is 98.05% effective in detec...
2021-04-15 14:20
2404
Seegene's Italy subsidiary secures public procurement for 7.15 million COVID-19 diagnostic tests, the largest tender in history
* Seegene's Italian subsidiary to supply some 7.15 million COVID-19 tests to 17 regions there * S. Korean biotechnology firm to expand its influence in Italy's PCR diagnostic industry SEOUL, South Korea, April 15, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a leading molecular diagnostics ...
2021-04-15 14:19
1585
US online retailer iHerb launches a promotional event during April
HONG KONG, April 15, 2021 /PRNewswire/ -- With April here before we realize it, many are already making travel plans and developing a routine for getting back in shape, signaling their pursuit of a happier and healthier lifestyle. The demand for nutritional supplements that enhance health is on t...
2021-04-15 10:09
1951
Adlai Nortye Announces First Patient Dosed in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
HANGZHOU, China, April 14, 2021 /PRNewswire/ -- Adlai Nortye, a global biopharmaceutical company focused on developing innovative oncology drugs, today announced that the first patient has been dosed in the global phase III clinical trial (BURAN) at Shanghai Eastern Hospital Medical Center inChin...
2021-04-15 09:00
2063
Everest Medicines Appoints Jennifer Yang as Chief Scientific Officer
SHANGHAI, April 15, 2021 /PRNewswire/ -- Everest Medicines
2021-04-15 08:36
4895
Week's Top Stories
Most Reposted
Multiple achievements made in China-Hungary BRI conference
[Picked up by 319 media titles]
2024-05-03 06:59
Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity
[Picked up by 316 media titles]
2024-05-07 08:00
Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 289 media titles]
2024-05-03 06:25TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 262 media titles]
2024-05-02 01:21
China-Serbia forum highlights community with shared future for mankind
[Picked up by 245 media titles]
2024-05-01 11:39
Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
13580
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
9405
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
8925
